Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lincy S Lal

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
BJU International|March 2, 2011
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centreEric Jonasch, Lincy S Lal, Bradley J Atkinson, et al.
Journal of Oncology Practice|November 28, 2012
Low rates of hepatitis B virus screening at the onset of chemotherapyJessica P Hwang, Michael J Fisch, Hong Zhang, et al.
Journal of Palliative Care|April 26, 2022
Palliative Care Consultation in the Intensive Care Unit Reduces Hospital Costs: A Cost-AnalysisTong Han Chung, Linh K Nguyen, Lincy S Lal, et al.
The Journal of Behavioral Health Services & Research|August 21, 2024
Disparities and Medical Expenditure Implications in Pediatric Tele-Mental Health Services During the COVID-19 Pandemic in MississippiYunxi Zhang, Lincy S Lal, Yueh-Yun Lin, et al.
International Journal of Environmental Research and Public Health|July 27, 2024
Tele-Mental Health Service: Unveiling the Disparity and Impact on Healthcare Access and Expenditures during the COVID-19 Pandemic in MississippiYunxi Zhang, Lincy S Lal, Yueh-Yun Lin, et al.
American Journal of Clinical Oncology|February 5, 2011
Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastasesLincy S Lal, Stacey DaCosta Byfield, Eric L Chang, et al.
BMC Health Services Research|July 22, 2020
The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment programTong Han Chung, Ricardo J Hernandez, Anaelle Libaud-Moal, et al.
The Oncologist|May 6, 2021
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint InhibitorsSaby George, Elizabeth J Bell, Ying Zheng, et al.
The Oncologist|November 20, 2024
Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitorsJarushka Naidoo, Douglas B Johnson, Charlotte Doran, et al.
Arthritis Care & Research|June 20, 2020
Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping StrategiesAliza R Karpes Matusevich, Zhigang Duan, Hui Zhao, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
BJU International|March 2, 2011
Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centreEric Jonasch, Lincy S Lal, Bradley J Atkinson, et al.
Journal of Oncology Practice|November 28, 2012
Low rates of hepatitis B virus screening at the onset of chemotherapyJessica P Hwang, Michael J Fisch, Hong Zhang, et al.
Journal of Palliative Care|April 26, 2022
Palliative Care Consultation in the Intensive Care Unit Reduces Hospital Costs: A Cost-AnalysisTong Han Chung, Linh K Nguyen, Lincy S Lal, et al.
The Journal of Behavioral Health Services & Research|August 21, 2024
Disparities and Medical Expenditure Implications in Pediatric Tele-Mental Health Services During the COVID-19 Pandemic in MississippiYunxi Zhang, Lincy S Lal, Yueh-Yun Lin, et al.
International Journal of Environmental Research and Public Health|July 27, 2024
Tele-Mental Health Service: Unveiling the Disparity and Impact on Healthcare Access and Expenditures during the COVID-19 Pandemic in MississippiYunxi Zhang, Lincy S Lal, Yueh-Yun Lin, et al.
American Journal of Clinical Oncology|February 5, 2011
Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastasesLincy S Lal, Stacey DaCosta Byfield, Eric L Chang, et al.
BMC Health Services Research|July 22, 2020
The evaluation of comprehensive medication management for chronic diseases in primary care clinics, a Texas delivery system reform incentive payment programTong Han Chung, Ricardo J Hernandez, Anaelle Libaud-Moal, et al.
The Oncologist|May 6, 2021
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint InhibitorsSaby George, Elizabeth J Bell, Ying Zheng, et al.
The Oncologist|November 20, 2024
Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitorsJarushka Naidoo, Douglas B Johnson, Charlotte Doran, et al.
Arthritis Care & Research|June 20, 2020
Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping StrategiesAliza R Karpes Matusevich, Zhigang Duan, Hui Zhao, et al.
Pageof 6